Henry Ford Health System Study: Hydroxychloroquine Lowers COVID-19 Death Rate by Half

“Our analysis shows that using hydroxychloroquine helped saves lives,” said Steven Kalkanis, CEO, Henry Ford Medical Group and Senior Vice President and Chief Academic Officer of Henry Ford Health System. “As doctors and scientists, we look to the data for insight. And the data here is clear that there was benefit to using the drug as a treatment for sick, hospitalized patients.”

The study analyzed 2,541 patients hospitalized between the system’s six hospitals between March 10 and May 2. The study found 13% of the patients treated with hydroxychloroquine died while 26.4% of the patients who did not receive the drug died.

Patients treated with hydroxychloroquine at Henry Ford met specific protocol criteria as outlined by the hospital system’s Division of Infectious Diseases. The vast majority received the drug soon after admission; 82% within 24 hours and 91% within 48 hours of admission. All patients in the study were 18 or over with a median age of 64 years; 51% were men and 56% African American.

for article, click below:

Source: Henry Ford Health System Study: Hydroxychloroquine Lowers COVID-19 Death Rate – CBS Detroit

Print Friendly, PDF & Email
Social media & sharing icons powered by UltimatelySocial

WPGrow